Creatine kinase is released from damaged skeletal (and cardiac) muscle. The clinical risk in a very high CK is rhabdomyolysis — myoglobin released from breaking-down muscle is filtered by the kidney and is directly nephrotoxic, precipitates in tubules, and (with the volume depletion that often accompanies the precipitant) causes acute kidney injury. Hyperkalaemia from muscle breakdown can be life-threatening independently. Because microscopy takes time, a positive dipstick for blood with no red cells on microscopy is treated as myoglobinuria — but you act on the clinical suspicion (dark urine + very high CK + a precipitant) without waiting. Autoimmune necrotising myositis is a rare but important mimic of simple statin myalgia: the key discriminator is that weakness is severe and continues to progress after the statin is stopped, whereas ordinary statin myopathy improves on withdrawal.

Because exercise is such a common and benign cause, a single mildly raised CK in a well person with a recent bout of exertion rarely needs a full myopathy work-up — the pragmatic step is to remove the precipitant (rest, hydration, hold any non-essential causative drug) and recheck after the muscle has recovered. Interpreting CK as a multiple of the ULN matters because reference ranges differ substantially between laboratories and are higher in men and in people of African ancestry, so an "absolute" number can mislead.

The single most useful clinical discriminator is whether there is true weakness (especially proximal) as opposed to pain alone: ache after exertion or with a statin is usually benign, whereas progressive proximal weakness points towards an inflammatory or hereditary myopathy and changes the threshold for referral and investigation. A careful drug and exertion history identifies the reversible drivers that account for most raised CK results, so they can be removed before any extensive work-up.

The degree of CK elevation guides both urgency and the breadth of investigation. Very high values are about preventing kidney injury (rhabdomyolysis); intermediate values prompt a structured search for a secondary cause; modest values in a well person are most often physiological and self-limiting. The bands are pragmatic multiples of ULN rather than fixed numbers because of inter-laboratory and sex variation.

Raised CK is frequently multifactorial — for example a statin plus alcohol plus a recent bout of unaccustomed exercise. The secondary panel screens for the common reversible drivers (thyroid and other endocrine disease, electrolyte and vitamin D abnormalities, renal impairment) so that the elevation is not wrongly attributed to a primary muscle disease. Persisting, unexplained elevation — particularly with weakness in someone over 50 — raises the possibility of an inflammatory myopathy, where rheumatology assessment and consideration of myositis-specific antibodies and imaging is worthwhile.

Most management is conservative: remove the precipitant, hydrate, and recheck. The key judgement is distinguishing the well patient with a transient, exercise-related rise (who needs reassurance and a recheck) from the patient whose CK reflects a treatable secondary cause or an evolving myopathy. Statin-related symptoms have their own structured pathway because many patients tolerate a re-challenge, a lower dose or an alternative statin, and unnecessary permanent discontinuation removes important cardiovascular protection.

Referral is reserved for the minority: those with a persistently unexplained or rising CK, with weakness suggesting an inflammatory or hereditary myopathy, where specialist investigation (antibodies, EMG, MRI, muscle biopsy or genetic testing) changes management. Most raised CK results are explained by a reversible cause found in primary care.

Because raised CK is usually multifactorial, the highest-yield intervention is simply removing the stacked muscle insults — recent unaccustomed exercise, alcohol, dehydration and a contributing drug — and then re-measuring once the muscle has recovered. Treating an under-recognised hypothyroidism or vitamin D deficiency can normalise a persistently raised CK without any need for myopathy investigation.

Rhabdomyolysis can evolve after the initial test, so a patient sent home with a moderately raised CK must know the warning features — severe pain, dark urine, reduced urine output — that mandate urgent reassessment. Following the trend rather than a single number distinguishes the transient, resolving rise from the persistent elevation that warrants a full work-up, and the progressive-weakness rule is the safety-net for the rare necrotising myositis that does not improve on statin withdrawal.